Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Martin Grussendorf"'
Autor:
Martin Grußendorf
Publikováno v:
MMW - Fortschritte der Medizin. 163:50-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5538eab69b37b88963cc71254051a99
https://doi.org/10.1007/s15006-021-0261-5
https://doi.org/10.1007/s15006-021-0261-5
Autor:
Martin, Grußendorf
Publikováno v:
MMW Fortschritte der MedizinLiteratur. 163(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec7708ee387353d2f41bf100f5d5ce40
https://pubmed.ncbi.nlm.nih.gov/34595648
https://pubmed.ncbi.nlm.nih.gov/34595648
Autor:
Christof Schöfl, David Petroff, Jochen Schopohl, Michael Droste, Martin Grussendorf, Günter K. Stalla, Anke Tönjes, C. Jaursch-Hancke, Sylvère Störmann
Publikováno v:
Pituitary. 20:635-642
Acromegaly is a rare disease generally brought about by a benign tumour in the pituitary and characterized by growth hormone (GH) and insulin-like growth factor 1 (IGF-1) excess. Increased mortality has been related to cardiovascular events that coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6066915eb4b7ef03b8cb3179049e37f
https://doi.org/10.1007/s11102-017-0827-5
https://doi.org/10.1007/s11102-017-0827-5
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16680e28e811282d88008f8b2b410291
https://doi.org/10.1530/endoabs.49.oc10.1
https://doi.org/10.1530/endoabs.49.oc10.1
Autor:
Christof Schöfl, Holger Franz, Martin Grussendorf, Jürgen Honegger, Cornelia Jaursch-Hancke, Bernhard Mayr, Jochen Schopohl
Publikováno v:
European Journal of Endocrinology. 168:39-47
BackgroundAcromegaly is a rare disease with significant morbidity and increased mortality. Epidemiological data about therapeutic outcome under ‘real life’ conditions are scarce.ObjectiveTo describe biochemical long-term outcome of acromegaly pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708c74e7615b96a912d607e20df839d7
https://doi.org/10.1530/eje-12-0602
https://doi.org/10.1530/eje-12-0602
Autor:
Martin Grußendorf
Die „Therapie der diffusen und nodösen Struma im Wandel der Zeiten“ war das Thema der 20. Konferenz über die menschliche Schilddrüse, die im Oktober 2011 in Heidelberg stattfand. Obwohl in Deutschland seit Jahrzehnten Millionen von Patienten m
Autor:
Andreas Bockisch, Joachim Feldkamp, Klaus Mann, Anja Eckstein, Christoph Reiners, Beate Quadbeck, George J. Kahaly, Matthias Schott, Martin Grußendorf
Publikováno v:
Medizinische Klinik. 104:343-348
Graves' disease (GD) is the only autoimmune disease where autoantibodies stimulate the target organs. Among the most common clinical manifestations are hyperthyroidism and orbitopathy (GO). To ensure the diagnosis of autoimmune hyperthyroidism, activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06f259789ef873630466193b3dcef596
https://doi.org/10.1007/s00063-009-1072-0
https://doi.org/10.1007/s00063-009-1072-0
Autor:
Christina Dimopoulou, Christof Schöfl, Günter K. Stalla, Manuel Mai, Martin Grussendorf, Anke Tönjes, David Petroff, C. Jaursch-Hancke, Michael Droste, Jochen Schopohl
Publikováno v:
The Journal of clinical endocrinology and metabolism. 100(10)
Acromegaly is a rare disease characterized by high serum levels of GH and IGF-1. Animal studies have demonstrated links between these hormones and cancer, but data regarding cancer incidence among acromegaly patients are inconsistent. Moreover, thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf995730d940a12dbc10454fe8a0ed8
https://pubmed.ncbi.nlm.nih.gov/26244491
https://pubmed.ncbi.nlm.nih.gov/26244491
Autor:
Christof Schöfl, Martin Grussendorf, Jürgen Honegger, Anke Tönjes, Daniel Thyroke-Gronostay, Bernhard Mayr, Jochen Schopohl
Publikováno v:
European journal of endocrinology. 172(4)
ContextDisease control is a prime target in acromegaly treatment. This should be achievable in the vast majority of patients by available treatment options. For unknown reasons, however, a significant number of patients do not achieve disease control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a28504f4779d174bbe42cefc2827f2
https://pubmed.ncbi.nlm.nih.gov/25599707
https://pubmed.ncbi.nlm.nih.gov/25599707
Autor:
Martin Grussendorf, Christoph Reiners, Renate Vaupel, Karl Wegscheider, und die LISA-Studiengruppe
Publikováno v:
Medizinische Klinik. 100:542-546
Obwohl Levothyroxin in Deutschland das am haufigsten verschriebene Medikament ist, wurden bisher keine randomisierten, plazebokontrollierten Studien uber den Erfolg einer medikamentosen Therapie der Struma nodosa mit ausreichender Fallzahl durchgefuh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe39c68a45442f02d08b919f992fe7e3
https://doi.org/10.1007/s00063-005-1074-5
https://doi.org/10.1007/s00063-005-1074-5